Industry News

Immunotherapy Targets HPV-Related Head and Neck Cancer

A novel vaccine therapy can generate immune responses in patients with head and neck squamous cell carcinoma (HNSCCa), according to the Abramson Cancer.

Read More
Industry News

Rock Star and Oral Cancer Survivor Launches Immunotherapy Fundraiser

Drummer Rikki Rockett has a different outlook on life as he heads out on tour with his band Poison this spring. A year.

Read More
Industry News

Immunotherapy Improves Survival Rates of Advanced Head and Neck Cancer Patients

A new immunotherapy drug known as nivolumab greatly improves survival for patients with relapsed head and neck cancer, as more than twice as.

Read More
Industry News

Rocker Beats Oral Cancer with Immunotherapy

Rikki Rockett, drummer with the rock band Poison, was diagnosed with oral cancer a little more than a year ago. Now, the tumor.

Read More
Industry News

Rocker Beats Oral Cancer with Immunotherapy

Rikki Rockett, drummer with the rock band Poison, was diagnosed with oral cancer a little more than a year ago. Now, the tumor.

Read More
Industry News

Deal Inked for Oral Cancer Vaccine Research

UbiVac and Janssen Biotech will collaborate in preclinical and clinical versions of UbiVac’s proprietary DRibble immunotherapy for use in preclinical studies of oral.

Read More
WordPress Ads